Oman’s Health Technology Industry Landscape and Outlook: Business and Investment Opportunities

Oman’s health technology sector entered a more policy-defined implementation phase in 2026. The 11th Five-Year Plan (2026–2030) entered execution in January, the Ministry of Health (MOH) issued the National Guideline for Telehealth Services in December 2025, and Oman’s national digital-health infrastructure is expanding, supported by Al-Shifa, telehealth guidelines, and wider investment in health-system modernization.

Foreign businesses evaluating Gulf Cooperation Council (GCC) entry typically anchor on the United Arab Emirates (UAE) or Saudi Arabia first, and Oman rarely features in a first-pass scan. That reflex is becoming outdated. According to market estimates, Oman’s healthcare market is valued at US$1.66 billion in 2025 and projected to reach US$2.02 billio…, while the country’s broader healthcare system is already operating at scale. This article maps the landscape, regulatory framework, growth drivers, and investment opportunities foreign investors should weigh.

Oman’s health technology market at a glance

Oman’s healthcare market is on a steady mid-single-digit growth path. The sector is expanding at a compound annual growth rate of 5.16 percent. That growth sits on top of an already substantial public healthcare system, which remains the market’s primary anchor for technology procurement. The Ministry of Health runs the bulk of inpatient and primary care capacity nationally, making public-sector channels the first reference point for most foreign entrants.

The private sector is expanding in parallel, particularly in specialist and higher-acuity care, which is increasing demand for advanced diagnostics, workflow software, and digital care tools. Together, this creates a two-track buyer landscape for foreign businesses, spanning large-scale public tenders and faster-moving private contracts.

Insurance digitization is reshaping the commercial layer. The Dhamani platform is moving claims processing, provider approvals, and insurer-provider workflows onto common digital infrastructure, opening revenue-cycle management, claims automation, and interoperability tools to new entrants.

The regulatory framework: who licenses what

Oman’s health technology regulation sits with a small set of authorities that foreign entrants need to map before entering the market. The Ministry of Health is the primary sector regulator, setting policy, licensing facilities and practitioners, and overseeing compliance across public and private providers.

Facility licensing runs through the Directorate General of Private Health Establishments, which handles approvals for hospitals, clinics, and specialist centers. Practitioner licensing sits operationally with the Ministry of Health, while the Oman Medical Specialty Board supports specialist training, examinations, and professional competence. For foreign investors, this means clinical services typically require dual compliance at both the entity and professional levels.

Commercial entry runs on a parallel track. Invest Oman provides investment facilitation, while commercial registration and sector-specific approvals follow standard government licensing processes through the Ministry of Commerce, Industry, and Investment Promotion (MoCIIP).

Telehealth now has a clearer regulatory framework in Oman, even if the wider digital-health environment still spans multiple authorities. For telehealth specifically, the Ministry of Health’s National Guideline for Telehealth Services Delivery in Oman, issued in December 2025, standardizes implementation and service-delivery expectations across healthcare institutions, while also referencing compliance requirements for private telehealth services. Oman’s Personal Data Protection Law (PDPL) covers processing of health and location data, which is a material consideration for software-as-a-service products, mobile health applications, and remote care platforms handling patient information.

Medical devices sit under a separate approval track, with registration and approval requirements applying to both foreign manufacturers and locally produced equipment. The Dhamani platform, meanwhile, is moving insurance transactions onto shared digital infrastructure, linking healthcare service providers, insurers, and related stakeholders, and opening a clearer compliance pathway for claims and insurtech entrants.

The regulatory map below summarizes the main authorities and requirements relevant to foreign health-technology investors.

Growth drivers: four forces converging in the 2026–2030 window

Policy pull

The 11th Five-Year Plan (2026–2030) has elevated the digital economy to a core pillar of Oman’s development agenda, with health technology sitting squarely within that pillar. Oman Vision 2040 anchors the broader modernization framing, treating healthcare as a priority social and economic sector. The MOH has publicly committed to deploying artificial intelligence (AI) diagnostics and expanding precision medicine, signaling clear procurement direction for foreign vendors.

Demographic pull

Oman’s population is aging, driving sustained demand for chronic care and long-term condition management. Non-communicable disease (NCD) burden is rising across all governorates, while a structural shortfall in qualified medical professionals makes workflow automation, decision support, and remote care tools commercially attractive rather than optional.

Infrastructure readiness

Al-Shifa provides a national digital-health backbone connecting more than 200 public health institutions across the country, giving new entrants a concrete reference point for integration. Telehealth has clearer operational guidance following the December 2025 National Guideline. Imaging and laboratory infrastructure are being upgraded in parallel, narrowing the gap between frontline clinical workflows and back-office systems.

Capital environment

One hundred percent foreign ownership is now permitted in most sectors, removing previous local sponsor requirements. Free trade agreements with the United States and Singapore provide meaningful export optionality. The headline corporate tax rate sits at 15 percent, with no personal income tax, and free zones offer tax holidays of up to 10 years.

Where the investment opportunities are

Digital health

Digital health is the most immediate opportunity, largely because the regulatory path is now mapped. Telemedicine and virtual care platforms can operate under a defined licensing framework following Ministerial Decision 109/2020 and the December 2025 National Guideline. Electronic health records and workflow tools are in demand as hospitals upgrade clinical documentation. Claims automation and insurer-provider integration open up alongside Dhamani’s rollout, while remote monitoring for chronic disease management aligns with the MOH’s NCD strategy and the workforce shortfall.

Medtech and diagnostics

AI-enabled diagnostics and screening tools align with stated MOH priorities. Imaging and Picture Archiving and Communication System (PACS)-related solutions are tied to current implementation activity, including the Ministry of Health’s February 2026 agreement to support PACS deployment across 10 referral hospitals. Laboratory technology and public-health testing systems present a parallel opportunity, particularly in diagnostics platforms and lab information systems. Specialty care technology for higher-acuity providers offers a narrower but higher-margin entry point.

Manufacturing and localization

Medical devices manufacturing and assembly benefit from free zone incentives and preferential market access. Pharmaceutical and medical-supplies localization is a stated government priority under the 11th Five-Year Plan. Export-oriented production linked to Sohar, Duqm, and Salalah free zones can serve markets across the Middle East and East Africa, with industrial partnerships positioning Oman as a logistics and assembly hub rather than a pure domestic market.

Who is buying health technology in Oman

Demand is concentrated across four buyer groups: MOH-linked hospitals, private hospitals and specialty clinics, insurers and third-party claims administrators, and independent labs and imaging operators. The table below maps these buyers against the main opportunity segments.

Market entry routes and commercial structuring

Sequencing matters when entering Oman’s health technology market. Invest Oman supports investment facilitation, while business establishment, commercial registration, and licensing proceed through the MoCIIP’s standard government processes. MOH establishment licensing follows, covering the facility or service entity, with professional licensing required where clinical services are delivered directly. Telemedicine entrants must additionally meet the conditions set out in Ministerial Decision 109/2020, and PDPL compliance applies throughout any activity involving patient data.

Find Business Support

Get help navigating Oman's tax system with tailored planning and compliance solutions across jurisdictions.

Investors have two main structuring options. Mainland registration allows 100 percent foreign ownership in most sectors, while free zones remain attractive for manufacturing and export-oriented activities. Public-private partnership (PPP) pathways are being actively promoted under the 11th Five-Year Plan, offering an additional route for infrastructure-linked technology deployments.

Risks and constraints foreign investors should weigh

Oman’s entry case is not friction-free. The absolute market is smaller than the UAE or Saudi Arabia, which means regional scale typically requires a multi-market go-to-market rather than a single-country rollout. Smaller private facilities face high initial technology adoption costs, concentrating the addressable buyer set among larger public and private institutions.

Procurement timing adds a further layer. Public-sector tenders are tied to 11th Five-Year Plan execution cycles, which can extend sales cycles in MOH-linked channels relative to private-sector equivalents. Partnership-led entry, through joint ventures or distribution agreements with established Omani providers, is often more practical than direct scaling, particularly for entrants without prior GCC exposure.

These constraints shape entry strategy rather than rule it out, and foreign investors who design for them from the start tend to move faster than those treating Oman as a standard GCC deployment.

Outlook: the 2026–2030 window

The 2026–2030 period offers a clearer policy window for foreign health-technology firms assessing Oman as either a secondary GCC market or a targeted manufacturing and service base. Two entry profiles stand out.

Find Business Support

Get help with setting up your Middle East business from our experienced corporate establishment and structuring specialists.

The first is Oman as a secondary GCC deployment market. Health technology companies with a UAE or Saudi anchor can treat Oman as a natural second market in telemedicine, electronic health records, and remote patient monitoring, where Al-Shifa’s scale and the clearer telehealth framework improve implementation conditions.

The second is Oman as a manufacturing and export platform. Invest Oman has flagged pharmaceutical security as a priority sector for 2026–2028, which positions medical devices producers and pharmaceutical manufacturers to benefit from aligned policy signals, free trade agreement access to the United States and Singapore, and free zone tax holidays of up to 10 years, with Sohar and Duqm offering logistics infrastructure to serve the wider Middle East and East Africa markets.

Public procurement pacing, workforce readiness, and regional capital flows will determine how far the window extends.

• Previous Article UAE Dubai South Free Zone Rolls Out New Incentives: What Investors Need to Know
• Next Article